Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

NCT01240525 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndrome

Interventions

OTHER: CD4 DLI
OTHER: No DLI

Sponsor

University College, London